Johnson & Johnson(JNJ)
175.48
Change: -0.25 (▼ -0.14%)
As of Tue 12/20/2022 05:34 PM% Of Value
Growth
Value Per Share
:
:
:
376.55
13.55
50.0000 (as of 19/12/2022)
Fundamentals Data
| Open | 175.35 | Dividend | 2789 |
| Close Price | 175.48 | DivYield | 2.7 % |
| High | 176.165 | Growth | 11.1 B |
| Low | 174.07 | Growth% | 13.55 |
| P/e | 23.738 | Volume | 5.7 M |
| P/b | 5.37 | Market Capital | 461.2 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 172.91 (as of 21/12/2022) | 50 Days Moving Average Percentage | 1.4628447686346 (as of 21/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / | Year3 / | Year4 / 2021 | Current Year / 2022 |
| Revenue | 0.0 | 0.0 | 0.0 | 82.5 B | 93.7 B |
| Cap Spending | 0.0 | 0.0 | 0.0 | -3.3 B | -3.6 B |
| Operating Expenses | 0.0 | 0.0 | 0.0 | 34.6 B | 40.5 B |
| Operating Cash Flow | 0.0 | 0.0 | 0.0 | 19.4 B | 23.3 B |
| Free Cash Flow | 0.0 | 0.0 | 0.0 | 20.1 B | 19.7 B |
| Free Cash Flow Per Share | 7.668 | 7.507 | |||
| Total liabilities | 0.0 | 0.0 | 0.0 | 35.2 B | 33.7 B |
| Total cash | 0.0 | 0.0 | 0.0 | 13.9 B | 14.4 B |
| ROE% | 0.234 | 0.299 | |||
| Outstanding Shares | 0.0 | 0.0 | 0.0 | 2.6 B | 2.6 B |
| P/E | 28.918 | 20.929 | |||
| P/S | 5.152 | 4.66 | |||
| Revenue USD | 0.0 | 0.0 | 0.0 | 82.5 B | 93.7 B |
Reports for JNJ
| Date | Author | Title | Action |
| 2016-09-05 | stanko | johnson and jjohnson, large swath of companies acquired using 26 billion debt load | view |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|